DE60113569D1 - Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem - Google Patents

Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem

Info

Publication number
DE60113569D1
DE60113569D1 DE60113569T DE60113569T DE60113569D1 DE 60113569 D1 DE60113569 D1 DE 60113569D1 DE 60113569 T DE60113569 T DE 60113569T DE 60113569 T DE60113569 T DE 60113569T DE 60113569 D1 DE60113569 D1 DE 60113569D1
Authority
DE
Germany
Prior art keywords
treatment
medium
hydroxy derivative
vascular
lymphoidem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60113569T
Other languages
English (en)
Other versions
DE60113569T2 (de
Inventor
Massimo Chimenti
Andrea Fratter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mac Pharma Sasdi Paola Michieletto & C Trevis
Original Assignee
Mac Pharma Sas Treviso
Mac Pharma S A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mac Pharma Sas Treviso, Mac Pharma S A S filed Critical Mac Pharma Sas Treviso
Application granted granted Critical
Publication of DE60113569D1 publication Critical patent/DE60113569D1/de
Publication of DE60113569T2 publication Critical patent/DE60113569T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60113569T 2001-12-04 2001-12-04 Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem Expired - Lifetime DE60113569T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000613 WO2003047566A1 (en) 2001-12-04 2001-12-04 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema

Publications (2)

Publication Number Publication Date
DE60113569D1 true DE60113569D1 (de) 2006-02-02
DE60113569T2 DE60113569T2 (de) 2006-05-04

Family

ID=11133762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113569T Expired - Lifetime DE60113569T2 (de) 2001-12-04 2001-12-04 Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem

Country Status (6)

Country Link
EP (1) EP1450788B8 (de)
AT (1) ATE304847T1 (de)
AU (1) AU2002217430A1 (de)
DE (1) DE60113569T2 (de)
ES (1) ES2249391T3 (de)
WO (1) WO2003047566A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003865A1 (en) * 1984-03-01 1985-09-12 Casley Smith John Royle Treatment of high protein oedemas in animals
GB2168696B (en) * 1984-12-21 1989-01-11 Boehringer Biochemia Srl Fluoro coumarins as antilymphoedema agents
US4616033A (en) * 1985-03-14 1986-10-07 Lamorna Investments Proprietary Ltd. 7 hydroxy-coumarin as a treatment for high protein oedemas
DE3715990C2 (de) * 1987-05-13 1993-10-28 Schaper & Bruemmer Gmbh Verwendung von Cumarin und 7-Hydroxy-cumarin
EP0668074B1 (de) * 1994-02-18 2001-05-09 Drossapharm AG Transdermales therapeutisches System
GB9722600D0 (en) * 1997-10-24 1997-12-24 Bio Monde Holdings Internation Pharmaceutical compositon

Also Published As

Publication number Publication date
DE60113569T2 (de) 2006-05-04
EP1450788A1 (de) 2004-09-01
EP1450788B1 (de) 2005-09-21
EP1450788B8 (de) 2006-05-03
AU2002217430A1 (en) 2003-06-17
WO2003047566A1 (en) 2003-06-12
ATE304847T1 (de) 2005-10-15
ES2249391T3 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
MA28102A1 (fr) Formulations pharmaceutiques, methodes et schemas d'administration pour le traitement et la prevention des syndromes coronariens aigus
FI972793A0 (fi) Nebivololin käyttö antiaterogeenisenä aineena
ME00548B (me) Korišćenje inhibitora il-18 za liječenje i/ili prevenciju perifernih vaskularnih bolesti
AR031117A1 (es) Uso de inhibidores de lipasa y secuestrantes de acido biliar para la preparacion de un medicamento, dicho inhibidor de lipasa y secuestrante de acido biliar y combinacion farmaceutica
HUP0401501A2 (hu) Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával
DE69607615D1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
PT876343E (pt) Ceto-acidos aromaticos e seus derivados como inibidores metaloproteinases de matriz
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
DE60115054D1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
DE60113569D1 (de) Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem
EA200601238A1 (ru) Медикаменты для профилактики и лечения бромидроза и для улучшения запаха тела
DE69904465D1 (de) Therapie von depressionen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE386513T1 (de) Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
DE60111571D1 (de) Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE60122781D1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
IT1306669B1 (it) Composizioni farmaceutiche comprendenti 8-cloro-3 (beta-dietilaminoetil) -4-metil-7-etossicarbonilmetossi cumarina base e
WO2000002578A8 (fr) Remedes contre les maladies liees a l'apoptose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MAC PHARMA S.A.S.DI PAOLA MICHIELETTO & C., TREVIS